Jan 16 (Reuters) - Swiss online drug retailer DocMorris reported higher fourth quarter external revenue as it continues to aim for profitability on an adjusted core earnings basis, excluding e-prescriptions, in 2024.

DocMorris' external revenue in the fourth quarter rose 10.8% year-on-year to 280.5 million Swiss francs ($326.66 million), 1.6% above analysts' estimate of 276 million Swiss francs in a company-compiled consensus. ($1 = 0.8587 Swiss francs) (Reporting by Tristan Veyet and and Chiara Holzhaeuser in Gdansk; Editing by Christian Schmollinger)